Skip to main content
. 2013 Apr 21;19(15):2368–2373. doi: 10.3748/wjg.v19.i15.2368

Table 1.

Characteristics of patients and comparison of results of percutaneous biopsy with those of endoscopic ultrasound-guided fine-needle aspiration

Percutaneous biopsy EUS-FNA P value
Group A Group B
Patients 46 75
Site of puncture
Pancreas 46 74 > 0.9999
Head/body/tail 12/32/2 34/31/9   0.0114
Sex (male/female) 25/21 39/36 > 0.8525
Age, yr > 0.8466
≥ 65 28 48
< 65 18 27
Tumor diameter, mm (range) 44.8 (18-111) 25.5 (7-70)
≥ 40 30 25   0.0007
< 40 16 50
Passes (range) 2.26 (1-4) 2.85 (2-5) < 0.0001
Adequate specimens obtained1 n (%)
Cytology 42 (91.3) 75 (100)   0.0192
Histology 41 (89.1) 65 (86.7)   0.7812
Positivity for cancer n (%)
Cytology 33 (78.6) 72 (94.6)   0.0079
Histology 33 (80.5) 51 (78.4) > 0.9999
Total n (%) 43 (93.5) 73 (97.3)   0.3672
Complications n (%) 2 (4.3) 1 (1.3) > 0.5567
Fever1 Peritonitis1
Bleeding1
Time from puncture to definitive diagnosis
Cytology, d (range) 4.05 (0-8) 1.65 (0-5) < 0.0001
Histology, d (range) 3.95 (2-7) 3.18 (2-10)   0.7066
1

An on-site pathologist was available for endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) but not for ultrasonography-guided-FNA.